Sector ratings Laboratorios Farmaceuticos Rovi, S.A. OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
|
Market Closed -
OTC Markets
09:30:03 2026-08-03 EDT
|
5-day change | 1st Jan Change | ||
| 67.17 USD | +1.98% |
|
-.--% | +1.98% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,024B | A | |||||||
| 663B | - | BBB | - | - | ||||
| 453B | AA | - | ||||||
| 352B | AA | |||||||
| 304B | AAA | |||||||
| 252B | A | |||||||
| 236B | A | |||||||
| 206B | A | |||||||
| 187B | AA | |||||||
| 162B | A | |||||||
| 138B | AA | |||||||
| 136B | A | |||||||
| 106B | AA | |||||||
| 100B | AA | |||||||
| 71.64B | AA | |||||||
| 58.86B | AA | |||||||
| 55.77B | AA | |||||||
| 45.14B | AA | |||||||
| 42.37B | - | |||||||
| Average | 241.87B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
